SCHEMBL9807569

SCHEMBL9807569

O=[PH](Oc1cccc2ccccc12)c1cccc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 4/20 0.44
HSD17B10 Q99714 3/20 0.44
HPGD P15428 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
PGR P06401 1/20 0.41
GAA P10253 1/20 0.41
PTGS1 P23219 1/20 0.41
MAPK1 P28482 1/20 0.41
HTR1B P28222 5/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KCNA3 P22001 1/20 0.39
OGG1 O15527 1/20 0.38
HTR1D P28221 1/20 0.38
SLC6A4 P31645 1/20 0.37
HRH1 P35367 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7764949 0.94 ALDH1A1 (0.41) ALDH1A1KDM4EHSD17B10HPGDTDP1
SCHEMBL28870621 0.81 ALDH1A1 (0.47) ALDH1A1KDM4EHSD17B10HPGDTDP1
SCHEMBL9475688 0.81 KCNA3 (0.39) ALDH1A1KDM4EHSD17B10HPGDTDP1
SCHEMBL28171688 0.81 MAPT (0.42) ALDH1A1KDM4EHSD17B10HPGDTDP1
SCHEMBL81301 0.80 ALDH1A1 (0.49) ALDH1A1KDM4EHSD17B10HPGDTDP1
SCHEMBL3168240 0.77 ALDH1A1 (0.50) ALDH1A1KDM4EHSD17B10HPGDTDP1
SCHEMBL28448257 0.77 ALDH1A1 (0.50) ALDH1A1KDM4EHSD17B10HPGDTDP1
SCHEMBL29787414 0.77 ALDH1A1 (0.47) ALDH1A1KDM4EHSD17B10HPGDTDP1
SCHEMBL29633517 0.77 ALDH1A1 (0.50) ALDH1A1KDM4EHSD17B10HPGDTDP1
SCHEMBL28221900 0.76 ALDH1A1 (0.49) ALDH1A1KDM4EHSD17B10HPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190161418-A1 OIL-SOLUBLE PLANT MICRONUTRIENTS INDORAMA VENTURES OXIDES LLC 2019-05-30 US disclosed
EP-0199997-B1 PROCESS FOR PREPARING DIARYL-PENTAERYTHRITOL ADEKA ARGUS CHEMICAL CO., Ltd. (JP) 1991-05-29 EP disclosed
US-4739090-A REACTING PHOSPHOROUS TRICHLORIDE, PENTAERYTHRITOL, AND ALKYL PHENOL IN PRESENCE OF CATALYST ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1988-04-19 US disclosed
EP-0199997-A2 Process for preparing diaryl-pentaerythritol ADEKA ARGUS CHEMICAL CO., Ltd. (JP) 1986-11-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190161418-A1 OIL-SOLUBLE PLANT MICRONUTRIENTS PNPO, SLC19A1, SLC6A12 ALDH1A1 2750/4885KDM4E 3757/4885HSD17B10 858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.